Two of the PD risk SNPs were enriched in CD19+ B-lymphocytes, at enhancers for LRRK2 (chromosome 12) and at another locus (chromosome 14) the disruption of the glucocorticoid receptor response element. This evidence concerns the gene LRRK2 and Parkinson disease.